APF 2024: Insights for Innovation and Patient Care

At the 2024 MDIC Annual Public Forum, the “Data Horizons: Insights for Innovation and Patient Care” panel brought together leaders from healthcare, research, and regulation to discuss the evolving role of real-world data (RWD) and real-world evidence (RWE) in shaping medical technology’s future. The panel emphasized RWE’s potential to streamline regulatory pathways and improve access to life-saving devices, while acknowledging the need for broader adoption to maximize its impact.

APF 2024: Shifting Paradigms in the Women’s Health Conversation

Only in the last decade has the global community started to tackle inequities for women in healthcare, from equal representation in clinical trials to reduced mortality. This increased focus is a welcome step toward innovation that moves beyond male biology as a ‘norm’— yet a one-size-fits-all approach misses the mark when it comes to representation of diverse populations. At the MDIC Annual Public Forum experts in women’s health convened to discuss these persisting inequities in health and to share visions of potential pathways to more targeted, effective, and equitable care.

MDIC In the News: SRS Initiative Update

Following a meeting at the MDIC Annual Public Forum, Maryellen de Mars, MDIC’s program director of clinical diagnostics, said in an interview that the consortium’s Somatic Reference Samples Initiative recently confirmed that it has successfully engineered the 10 target reference lines and is ready to start its next steps to confirm its results and establish use cases.

MDIC In the News: Andy Fish on Driving Positive Change in the Medtech Ecosystem

Following a meeting at the MDIC Annual Public Forum, Maryellen de Mars, MDIC’s program director of clinical diagnostics, said in an interview that the consortium’s Somatic Reference Samples Initiative recently confirmed that it has successfully engineered the 10 target reference lines and is ready to start its next steps to confirm its results and establish use cases.